DKSH Acquires Healthcare Distributor Medipharm in Brunei

waiting on 1814549,news,reuters8

   DKSH Management Ltd. / Key word(s): Takeover
   DKSH Acquires Healthcare Distributor Medipharm in Brunei
   15.01.2024 / 07:00 CET/CEST
     ____________________________________________________________

Media release

DKSH has signed an agreement to acquire Medipharm Sdn Bhd ("Medipharm"), one
of the leading pharmaceutical and medical devices distributors in Brunei.
With this acquisition, DKSH Healthcare grows its business in line with the
strategy to expand its footprint in the Asia-Pacific region.

Zurich, Switzerland, January 15, 2024 - DKSH has announced today that it
signed an agreement to acquire Medipharm, one of the leading pharmaceutical
and medical devices distributors in Brunei. DKSH and Medipharm build on a
longstanding strategic partnership, with Medipharm having operated as DKSH's
sub distributor in Brunei for the last 25 years.

Medipharm generates net sales of more than CHF 30 million1 at good
profitability. With a team of over 50 people, the company serves renowned
blue-chip clients. Medipharm distributes pharmaceutical products, medical
devices, consumer health, personal care, and nutritional products. Its main
customers are hospitals, medical centers, clinics, opticians, and
pharmacies.

Bijay Singh, Head Business Unit Healthcare, said: "With the integration of
Medipharm, and Brunei being one of the few markets in Asia-Pacific with no
direct presence of DKSH Healthcare, we further increase our footprint,
enabling us to provide even more encompassing market coverage for our
clients. We warmly welcome all Medipharm employees at DKSH and look forward
to continuing our longstanding, successful partnership."

Pengiran Sharinah, Chairwoman of Medipharm, commented: "Since Medipharm was
founded in 1998, we have acted as a pivotal intermediary between our clients
and customers in the distribution of life-saving drugs and medical products.
The combination with DKSH marks the next milestone in our company history
and will equally benefit our clients, employees, and business partners. We
look forward to building on our joint expertise and continuing to pursue our
journey of growth."

¹ Exchange rate 1 Swiss Franc / 1.5 Brunei Dollar

About DKSH
DKSH's purpose is to enrich people's lives. For more than 150 years, we have
been delivering growth for companies in Asia and beyond across our Business
Units Healthcare, Consumer Goods, Performance Materials, and Technology. As
a leading Market Expansion Services provider, we offer sourcing, market
insights, marketing and sales, eCommerce, distribution and logistics as well
as after-sales services. DKSH is a participant of the United Nations Global
Compact and adheres to its principles-based approach to responsible
business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with
32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The
DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health
and over-the-counter (OTC) products as well as medical devices. With around
7,990 specialists, the Business Unit generated net sales of CHF 5.6 billion
in 2022. www.dksh.com/hec

For more information please contact:

DKSH Holding Ltd.

Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com

Melanie Grüter
Manager Group Media Relations
Phone +41 44 386 7211
melanie.grueter@dksh.com

____________________________________________________________

   End of Media Release
     ____________________________________________________________

   Language:    English
   Company:     DKSH Management Ltd.
                Wiesenstrasse 8
                8008 Zurich
                Switzerland
   Phone:       044 386 72 72
   E-mail:      media@dksh.com
   Internet:    www.dksh.com
   ISIN:        CH0126673539
   Valor:       12667353
   Listed:      SIX Swiss Exchange
   EQS News ID: 1814549

   End of News EQS News Service
     ____________________________________________________________

1814549 15.01.2024 CET/CEST